肥胖与代谢健康在慢性肾脏病中的意义
本文综述肥胖与代谢健康在CKD中的关系。肥胖通过直接和间接机制增加CKD风险,CKD患者可呈现肌少性肥胖等复杂代谢模式,晚期CKD中肥胖可能与更好生存相关。减重可改善血糖控制和心血管危险因素,并降低已有CKD患者的白蛋白尿,但对肾功能和生存的长期影响研究不足,干预应个体化。
要点
- 肥胖通过直接和间接机制增加CKD风险。
- CKD患者可呈现肌少性肥胖等复杂代谢模式。
- 减重可改善白蛋白尿,但长期肾脏获益需个体化评估。
核心结论
- 肥胖增加CKD风险,但CKD患者代谢模式复杂,减重干预应个体化。
研究设计与样本
- 综述,未报告具体检索范围与样本量。
主要发现
- 肥胖通过直接和间接机制增加CKD风险。
- CKD患者常呈现肌少性肥胖等复杂代谢模式,晚期CKD中肥胖可能与更好生存相关。
- 减重可改善血糖控制和心血管危险因素,并降低已有CKD患者的白蛋白尿。
临床怎么用
- 对CKD合并肥胖者应评估肌少性肥胖等代谢表型,个体化制定减重策略。
局限性
- 减重干预对CKD患者肾功能和生存的长期影响研究不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Obesity is a worldwide epidemic with a future projected growth of 40% over 10 years. Obesity increases the risk of diabetes, hypertension, and cardiovascular disease, and it also leads to higher risk of CKD, through both direct and indirect mechanisms. Although obesity is a feature of overnutrition and is associated with poor outcomes in the general population, obese individuals with CKD often display complex metabolic patterns such as sarcopenic obesity, and obesity can be associated with better survival in individuals with advanced CKD. Weight loss interventions are proven to improve glycemic control and cardiovascular risk factors, and successful weight loss is associated with improved albuminuria in patients with preexisting CKD. The long-term effects of weight loss interventions on kidney function and on survival in patients with CKD are less well studied, and hence, such interventions should be individualized.
引用
- Kovesdy CP. Obesity and Metabolic Health in CKD. Clin J Am Soc Nephrol. 2025. PMID: 40085173. doi:10.2215/CJN.0000000704
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。